Medicine shortages are "inevitable" given the number of prescriptions dispensed each year, health minister Simon Burns MP has said.
Pharmaceutical needs assessments (PNAs) might be used to govern market entry for pharmacies in Wales, according to a consultation published by the Welsh Government.
A booster dose of meningococcal C vaccine should be given to adolescents, and one dose removed from the vaccine dosage schedule for infants, the Joint Committee on Vaccination and Immunisation has advised.
Russian Foreign Minister Sergei Lavrov is in Syria for talks with President Bashar al-Assad amid an upsurge in violence in the restive city of Homs.
Women with a history of smoking may be at particular risk of hip fracture when using proton pump inhibitors (PPIs) long-term, according to a BMJ study.
A total of 434 pharmacy contractors requested a total of 5,623 prescription payment checks from the NHS Business Services Authority, due to possible errors caused by the computerised pricing system over the past three years.
Tighter controls are needed over the online advertising of prescription drugs, researchers have concluded, after finding poor safety and side effects information on a number of websites selling statins to the public.
Heavy artillery fire has been rocking Homs, as Syrian troops step up an assault on the restive city.
Patients whose systolic blood pressure differs by 10mmHg or more between each arm are at increased risk of peripheral vascular disease and death, UK research suggests.
Four trustees have joined the board of the charity Pharmacist Support.
Hospital pharmacists wishing to refer patients for community pharmacy services can make use of a new referral form developed by NHS Employers, the PSNC and the RPS.
New resources to help pharmacists manage patients with persistent pain have been developed by UCL School of Pharmacy and the United Kingdom Clinical Pharmacy Association.
Ulipristal 5mg can control bleeding in patients with uterine fibroids, according to two studies published online today in the New England Journal of Medicine.
Dual treatment for HER2-positive breast cancer with lapatinib plus trastuzumab improves pathological complete response compared with monotherapy with either drug, according to data published online in The Lancet.
Nine serious incidents have been reported with England’s pilot NHS 111 telephone service, it has emerged.